The latest price list of temsilimumab

Introduction: Temimumab is a targeted drug used to treat small cell lung cancer (ES-SCLC). The original drug costs approximately US$32,277 per box. The high cost puts many patients under financial pressure. This article will focus on three aspects: price list, medication preparation and contraindications to help patients and their families fully understand the use information of this drug.

The latest price list of temsitumumab

is an innovative anti-cancer drug with a relatively high price, about US$32,277 per box. Since this drug has not yet been included in the medical insurance systems of most countries, patients need to bear the cost of treatment out of their own pocket.

Price components

The high price of temsitumumab is mainly due to factors such as research and development costs, production technology and patent protection. Biopharmaceuticals have long R&D cycles and high investments, and these costs are ultimately reflected in drug pricing.

Price differences in different regions

Although the prices of original drugs are unified, there may be differences in taxes and transportation costs in various regions. Some countries or regions may offer patient assistance programs to reduce the financial burden.

Comparison of alternatives

Currently, there is no generic drug that is completely equivalent to temsitumumab on the market. Patients need to choose a treatment plan according to their own situation. Some medical institutions may provide installment payments or charitable assistance projects.

Understanding drug price information can help patients make financial plans and promote the introduction of more policies to benefit the people.

Preparation for the use of temsitumumab

Comprehensive medical evaluation and preparation are required before using temsitumumab, which is crucial to the therapeutic effect.

Medical evaluation requirements

Patients need to complete blood tests, imaging evaluations and other tests to confirm that they are suitable for treatment with this drug. Doctors will develop a plan based on tumor type, stage, and the patient's overall health.

Pre-medication examination items

Routine examinations include liver function, kidney function, electrocardiogram, etc. These examinations can help identify potential risks and avoid serious adverse reactions.

Psychological and life preparation

Patients and family members should understand the possible side effects of treatment and prepare themselves mentally. Arrange daily life appropriately to ensure adequate rest and nutritional support during treatment.

Adequate medication preparation can improve treatment compliance and lay a good foundation for subsequent treatment.

Contraindications of temsitumumab

Clear contraindications of temsitumumab are crucial to ensuring patient safety, and strict screening is required before use.

Absolute contraindications

People who are allergic to drug ingredients, patients with severe immunodeficiency and pregnant women are prohibited from using this drug. Use in these cases may be life-threatening.

Relative contraindications

Patients with active infection and moderate to severe hepatic and renal insufficiency need to carefully evaluate the risk-benefit ratio. Your doctor may adjust the dose or choose an alternative treatment.

Restrictions on Special Populations

The safety of use in children, the elderly and lactating women has not been fully established and requires individualized evaluation. Clinical trial data are relatively limited in these groups.

Strict control of contraindications can minimize the risks of treatment.